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In order to define which structure of a-melanocyte-stimulating hormone (MSH) analogues plays a critical role for
ligand±receptor interaction and selectivity, we analysed receptor-binding and cAMP-generating activity in
Chinese hamster ovary cell lines stably transfected with rMC3R and hMC4R, as well as the NMR structures
of chemically synthesized a-MSH analogues. Compared with [Ahx4]a-MSH, the linear MTII designated as
a-MSH-ND revealed a preference for the MC4R, whereas its IC50 and EC50 values were comparable to those
of MTII reported previously. Truncation of Ahx4 and Asp5 of a-MSH-ND remarkably decreased the receptor-
binding and cAMP-generating activity. Meanwhile, maximum cAMP-generating activity was observed at a
higher concentration (1025 m) of a-MSH-ND(6±10), and MC4R preference was changed into MC3R preference.
In contrast, [Gln6]a-MSH-ND(6±10) lost its cAMP-generating activity almost completely, even though it
bound to both receptors. Whereas the solution conformation of a-MSH-ND revealed a stable type I b-turn
structure, [Gln6]a-MSH-ND(6±10) revealed a tight g-turn composed of Gln6-d-Phe7-Arg8. Replacement of
the His6 residue of a-MSH-ND by Gln, Asn, Arg or Lys decreased not only the receptor binding, but also the
cAMP-generating activity in both the MC3R and the MC4R. The structure of [Gln6]a-MSH-ND exhibited a
stable type I 0 b-turn comprising Asp5, Gln6, d-Phe7 and Arg8. [Lys6]a-MSH-ND showed a greatly reduced
binding affinity and cAMP-generating activity with the loss of MC4R selectivity. In NMR studies, [Lys6]a-
MSH-ND also demonstrated a g-turn conformation around Lys6-dPhe7-Arg8. From the above results, we
conclude that a type I b-turn conformation comprising the residues Asp5-His6-(d-Phe7)-Arg8 was important for
receptor binding and activation, as well as the selectivity of MSH analogues.
Keywords: melanocortin; melanocyte-stimulating hormone receptor; NMR; receptor-binding and cAMP-generating
activity; type I b-turn.
The peptide hormone precursor pro-opiomelanocortin (POMC)
is cleaved post-translationally to give rise to a variety of
biologically active substances called melanocortins [1],
including a-, b-, and g-melanocyte stimulating hormones
(MSH) and adrenocorticotropin. POMC gene expression is
limited to ARC (arcuate) neurones that project to areas that
express melanocortin receptors and participate in energy
homeostasis. As leptin receptors are expressed on POMC
neurones, melanocortin neurones appear to be a target of leptin
action [2]. Over the past several years, molecular cloning of the
five melanocortin receptor subtypes (MC1R±MC5R) has also
provided the tools for systemic studies of the molecular
mechanisms of their physiologic effects [3±7].
Mutations of the POMC gene in humans [8] or the MC4R
gene in mice [9] have resulted in obesity, whereas the
overexpression of agouti or agouti-related protein has also
induced obesity in mice [10,11]. Agonists of melanocortin
receptors elicit anorexia, whereas antagonists have the opposite
effect. Activation of the MC4R by a-MSH increases the energy
expenditure, decreases the food intake, and promotes sym-
pathetic activity [12]. All of these findings, directly or
indirectly, have provided evidence that melanocortin is
involved critically in the control of food intake and body
weight homeostasis, and that it could reduce adiposity in
patients with obesity [13,14]. As melanocortin has catabolic
effects, its analogue has been listed as one of the target
molecules for the medical treatment of obesity. Until now, most
a-MSH analogues have preferably bound to the MC3R and the
MC4R with high affinity. However, if melanocortin analogues
are to be developed as anti-obesity medicine, then one that is
MC4R-selective and has the least systemic side-effects will be
better, and it should preferably be developed as a small organic
compound to pass the blood±brain barrier easily. Therefore, the
structural and functional studies of a-MSH analogues are
critically important for the development of potent a-MSH
analogues satisfying the above requirements.
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NDP-MSH with a seven-lactam-ring structure has been
known as the most potent melanocortin agonist [15]. The
substitution of Phe7 in a-MSH to d-Phe7 increased the
receptor-binding and cAMP response, as well as MC4R
selectivity [16,17]. Furthermore, the substitution of d-Phe7
for Phe7 provided the insight that the core structure of a-MSH
analogues is critically important for ligand±receptor interaction
and selectivity [18]. Recently, we reported that a-MSH forms
a hairpin loop conformation, whereas a-MSH-ND prefers a
type I b-turn structure comprising the residues of Asp5-His6-
(d-Phe7)-Arg8 [19]. To study further the functional impor-
tance of the type I b-turn structure and to provide direction for
the future development of a-MSH analogues, we generated
several a-MSH analogues by not only deleting the Ahx 4 and
Asp5 residues of a-MSH-ND, but by also substituting the
His6 residue of a-MSH-ND with Gln, Asn, Arg or Lys.
These analogues were analysed for their receptor-binding and
cAMP-generating ability in Chinese hamster ovary (CHO) cell
lines stably transfected with rMC3R and hMC4R, and for their
NMR spectroscopy. Here, we suggest which structure is
important for receptor binding and activation as well as the
selectivtiy of these a-MSH analogues.
E X P E R I M E N T A L P R O C E D U R E S
Chemicals
All media and sera for cell cultivation were purchased from
Gibco-BRL. NDP-MSH and other chemicals were purchased
from Sigma unless specified otherwise.
Peptides synthesis
The peptides used in this study (except NDP-MSH) were
synthesized at the Korea Basic Science Institute (Seoul, Korea)
by use of the solid phase approach and purified by HPLC. The
peptide sequences were assembled with a Milligen 9050 (Fmoc
Chemistry). The correct molecular masses of the peptides were
confirmed by MS. For deprotection, a reagent mixture (88%
trifluoroacetic acid, 5% phenol, 2% triisopropylsilane, 5%
H2O; 2 h) was used. The raw peptides formed were purified by
HPLC (Delta PAK 15m C18 300 AÊ 3.9  150 mm column,
detection at 240 nm).
Expression of melanocortin receptor clones and cell culture
Both rat MC3R and human MC4R cDNA were cloned into the
expression vector pcDNAI neo. For receptor expression, CHO
cells were grown in F-12 medium with 10% foetal bovine
serum (FBS) and 95% O2 air/5% CO2 and transfected with
rMC3R- and hMC4R-pcDNAI neo, respectively, by a calcium
phosphate method. Briefly, 5±7  105 cells (approximately
80% confluent cultures) were plated per 10-cm culture dish the
day before they were transfected. Cells were fed with flash
complete culture medium containing 20 mm Hepes and
incubated at 95% O2 air/5% CO2. After 3±4 h, the medium
was discarded and 5 mL calcium phosphate-DNA precipitate
containing 25 mg DNA, 124 mm CaCl2, 140 mm NaCl, 25 mm
Hepes and 1.41 mm Na2HPO4 (pH 7.12) was added. The cells
were then incubated for 4 h with 97% O2 air/3% CO2, washed
with NaCl/Pi (137 mm NaCl, 2.68 mm KCl, 4.3 mm N2HPO4,
1.47 mm KH2PO4, pH 7.12), and shocked with glycerol buffer
(15% glycerol, 140 mm NaCl, 25 mm Hepes and 1.41 mm
Na2HPO4, pH 7.12), washed again with NaCl/Pi, and incubated
for an additional 36±48 h in complete F-12 medium. Cells
were then cultured in complete F-12 medium containing
0.5 mg´mL21 G418 (Geneticin; Life Technologies) until
G418-resistant colonies appeared. G418-resistant colonies
were picked out and subcultured for at least 10±14 days. Rat
MC3R- and human MC4R-expressing cells were identified by
screening more than 15 colonies and confirmed by assay of
[Ahx4]a-MSH-induced cyclic AMP accumulation and agonist-
induced inhibition of iodinated NDP-MSH binding to receptors.
Binding study
Iodinated NDP-MSH, [125I](iodotyrosyl2)-[Ahx4, d-Phe7]
a-MSH, was prepared by the modified chloramine-T
method as follows: 1 mCi (10 mL) Na[125I] (Amersham) was
added to 5 mg NDP-MSH in 100 mL 200 mm sodium
phosphate buffer (pH 7.2); 20 mL 2.8 mg´mL21 chloramine T
solution in 200 mm sodium phosphate (pH 7.2) was then added
for 15 s at which time the reaction was stopped with 50 mL of
3.6 mg´mL21 sodium metabisulfate. The reaction mixture was
then diluted in 1 mL of 0.1% BSA containing 0.1%
trifluoroacetic acid and purified by C18 Sep-Park cartridge
(Waters) and Sephadex G25 Gel Filtration Chromatography;
100 mL 0.1% BSA was added to all fractions containing
radioactivity. For binding assays, the stably transfected CHO
cells were plated 48 h before experiments in 24-well culture
plates (Falcon Plastics) at a density of 5  104 per well until
they were 90±95% confluent on the day of assay. Maintenance
media was removed and the cells were washed twice with
washing buffer (50 mm Tris/HCl, 100 mm NaCl, 5 mm KCl,
2 mm CaCl2, pH 7.2), and immediately incubated at 37 8C for
2 h with 0.25 mL binding buffer (containing 50 mm Tris/HCl,
100 mm NaCl, 5 mm KCl, 2 mm CaCl2, 5% Hanks' Balanced
Salt Solution, 0.5% BSA, pH 7.2) in each well containing a
constant concentration of [125I]NDP-MSH and appropriate
concentrations of the competing unlabelled ligand. At the end
of incubation, the plates were placed on ice for 15 min and
the cells were washed twice with 0.5 mL ice-cold binding
buffer and then detached from the plates using 0.5 mL
0.05 m NaOH twice (final volume, 1 mL). Radioactivity was
determined (Workman automatic gamma counter) and data
were analysed with a software package suitable for
radioligand binding data analysis (GraphPad Prism Pro-
gramme). Nonspecific binding was determined by measuring
the amount of [125I]NDP-MSH remaining bound in the
presence of 1025 m unlabelled NDP-MSH, and specific binding
was calculated by subtracting nonspecifically bound radio-
activity from total bound radioactivity. IC50 (nm) values were
reported as mean ^ SE. All binding assays were performed in
triplicate wells and repeated twice.
Cyclic AMP assay
The CHO cells expressing the receptors were grown to
confluence in 24-well plates. Cell culture medium was changed
to complete F-12 medium containing 10% FBS 3±4 h before
cells were treated with peptides. For assays, the medium was
removed and cells were washed with 0.5 mL cAMP-generating
medium containing 10% FBS, 2 mm 3-isobutyl-1-methyl-
xanthine, 0.1% BSA, 20 mm Hepes, 0.002% ascorbic acid in
complete F-12 Medium. cAMP-generating media (0.25 mL)
containing various concentrations of peptides were added and
the cells were incubated for 30 min at 37 8C. The media were
then discarded completely, and cells were frozen at 270 8C for
30 min and thawed at room temperature for 15±20 min. The
process of freeze±thawing was repeated twice more.
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Subsequently, the cells were detached from the plates with
1 mL 50 mm HCl solution per well, transferred to a 1.5-mL
Eppendorf tube, followed by a 10 min centrifugation at
1900  g. The supernatant was diluted 50-fold with radio-
immunoassay (RIA) buffer and cAMP concentration was
measured by cAMP 125I RIA Kit (INCSTAR) according to
the manufacturer's instructions. The mean values of the data
were fit to a sigmoid curve with a variable slope factor using the
nonlinear squares regression in a graphpad prism. EC50 (nm)
values were described as mean ^ SE. All of the cAMP assays
were performed in triplicate wells and repeated twice. Student's
t-test was used to determine the statistical significance of
changes in binding affinity and the potency of the peptides
(P , 0.05 was considered significant).
Preparation of NMR samples
Three a-MSH analogues, [Gln6]a-MSH-ND, [Gln6]a-MSH-ND
(6±10) and [Lys6]a-MSH-ND were dissolved in 90% H2O/10%
D2O or 99.99% D2O at pH 7.0 with 50 mm sodium phosphate
buffer. NMR samples with D2O were prepared after lyophil-
ization of an H2O sample. The final sample concentrations for
NMR measurements were 2 mm in 0.5 mL buffer solution.
NMR
NMR was carried out at 10, 20 and 30 8C on a Bruker
DRX-500 spectrometer equipped with a triple resonance probe
having x,y,z gradient coils. Most NMR spectra were recorded at
10 8C and some experiments were also recorded at 20 8C and
30 8C to calculate temperature coefficients. Pulsed-field
gradient techniques were used for all H2O experiments,
resulting in good suppression of the solvent signal. Two-
dimensional total correlation spectroscopy (TOCSY) [20] with
MLEV-17 mixing pulse of 69.7 ms and two-dimensional
nuclear Overhauser effect spectroscopy (NOESY) [21] using
100±600 ms mixing times were performed. Two-dimensional
rotating-frame Overhauser effect spectroscopy (ROESY) spectra
with 100±800 ms ROE mixing times was also recorded in D2O
solution. Two-dimensional double-quantum-filtered (DQF)
COSY spectra [22] were collected in H2O to obtain a vicinal
coupling constant. A series of one-dimensional NMR measure-
ments was made to identify slowly exchanging amide hydrogen
resonances on a freshly prepared D2O solution after lyophil-
ization of a H2O sample. All NMR experiments were
performed in the phase-sensitive mode using the time
proportional phase incrementation method [23] with 2048
data points in the t2 and 256 in the t1 domain.
All NMR data were processed using nmrPipe/nmrDraw
(Biosym/Molecular Simulations, Inc.) or xwinnmr (Bruker
Instruments) software. Processed data were analysed using
sparky 3.60 developed at UCSF on a Silicon Graphics Indigo2
workstation. Prior to Fourier transformation in the t1 dimension,
the first row was half-weighted to suppress t1 ridges [24].
DQF-COSY data were processed to 8192  1024 matrices to
obtain maximum digital resolution for coupling constant
measurements. The proton chemical shifts were referenced
with internal sodium 4,4-dimethyl-4-silapentane 1-sulfonate.
Structure calculations
The hybrid distance geometry and dynamical simulated-
annealing protocol with the xplor 3.81 (Biosym/Molecular
Simulations, Inc.) program on a Silicon Graphics Indigo2
workstation were used for structure calculations [25,26].
Distance geometry (DG) substructures were generated using a
subset of atoms and followed a refinement protocol described in
Lee et al. [27]. The target function for molecular dynamics and
energy minimization consisted of covalent structure, van der
Waals' repulsion, NOE and torsion angle constraints. Based on
cross-peak intensities in the NOESY/ROESY spectra with
mixing times of 100±600 ms, the distance constraints were
classified into three distance ranges: strong (0.18±0.27 nm),
medium (0.18±0.33 nm) and weak (0.18±0.50 nm). Pseudo-
atom corrections were also used for nonstereospecifically
assigned methylene protons, methyl groups and the ring
protons of phenylalanine residue [28]. The NOESY spectra
of [Gln6]a-MSH-ND, [Gln6]a-MSH-ND(6±10) and [Lys6]
a-MSH-ND yielded 58, 49 and 50 NOE constraints, respec-
tively. Constraints for the dihedral angles for all peptides were
also deduced on the basis of the 3JHNa coupling constants from
two-dimensional DQF-COSY spectra in H2O.
R E S U LT S
We designed and synthesized a series of new linear MSH
analogues in which the structures are aligned with NDP-MSH
and a-MSH-ND (Table 1). The rat MC3R DNA and human
MC4R DNA were stably and independently expressed in CHO
cells for competitive receptor binding with [125I]NDP-MSH as
a radioligand and a cyclic AMP accumulation test following
treatment with different ligands.
Table 1. Alignment of a-MSH, NDP-MSH, linear MTII(a-MSH-ND) with the new analogues evaluated in this study. All peptides have an acetyl-group
on the N terminus and an amide group on the C terminus. The main substituted amino acid residues are shown in italics.
Position
Peptide 1 2 3 4 5 6 7 8 9 10 11 12 13
[Ahx4] a-MSH Ser Tyr Ser Ahx Glu His Phe Arg Trp Gly Lys Pro Val
NDP-MSH Ser Tyr Ser Ahx Glu His d-Phe Arg Trp Gly Lys Pro Val
a-MSH-ND Ahx Asp His d-Phe Arg Trp Lys
[Gln6]a-MSH-ND Ahx Asp Gln d-Phe Arg Trp Lys
[Asn6]a-MSH-ND Ahx Asp Asn d-Phe Arg Trp Lys
[Arg6]a-MSH-ND Ahx Asp Arg d-Phe Arg Trp Lys
[Lys6]a-MSH-ND Ahx Asp Lys d-Phe Arg Trp Lys
a-MSH-ND(6±10) His d-Phe Arg Trp Lys
[Gln6]a-MSH-ND(6±10) Gln d-Phe Arg Trp Lys
[Asn6]a-MSH-ND(6±10) Asp d-Phe Arg Trp Lys
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Comparative study on receptor-binding activity of the
synthesized peptides
To investigate if the linear form of peptide could also show
certain biological activity as the cyclic form described before,
we first synthesized one peptide whose sequence was the same
as MTII, but being of linear form, designated a-MSH-ND. We
compared its binding affinity for the MC3R and MC4R with
two of the well-known MSH analogues, [Ahx4]a-MSH and
Fig. 1. Competition curves of a-MSH analogues obtained in CHO cell
lines stably transfected with MC3R and MC4R using a fixed
concentration of [125I]NDP-MSH and varying concentrations of the
unlabelled competing peptides. Each experiment was performed in
triplicate and repeated twice.
Fig. 2. Competition curves of a-MSH analogues obtained in CHO cell
lines stably transfected with MC3R and MC4R using a fixed
concentration of [125I]NDP-MSH and varying concentrations of the
unlabelled competing peptides. Each experiment was performed in
triplicate and repeated twice.
Table 2. IC50 values (mean ^ SEM) of MSH analogues obtained from computer analysis of competition curves on MC3R and MC4R transfected
CHO cells, together with the relative affinity ratios of the melanocortin receptor subtypes.
IC50 (nm)
Ratio of
Ligand MC3R MC4R MC3R/MC4R
NDP-MSH 0.3671 ^ 0.074 0.5659 ^ 0.194 0.65
[Ahx4]a-MSH 106.7 ^ 32.25 238.3 ^ 30.47 0.45
a-MSH-ND 47.2 ^ 9.08 6.7 ^ 1.07 7.04
[Gln6]a-MSH-ND 1074.0 ^ 120.01 112.0 ^ 25.94 9.59
[Asn6]a-MSH-ND 1998.0 ^ 363.34 171.2 ^ 14.81 11.67
[Arg6]a-MSH-ND 361.5 ^ 57.73 57.4 ^ 8.37 6.29
[Lys6]a-MSH-ND 3340.0 ^ 877.05 238.1 ^ 40.63 14.03
a-MSH-ND(6±10) 4730.0 ^ 1180.93 827.0 ^ 208.73 5.72
[Gln6]a-MSH-ND(6±10) 7156.0  5063.46 1297.0 ^ 392.28 5.52
[Asn6]a-MSH-ND(6±10) 6712.0 ^ 4169.22 1304.0 ^ 378.47 5.15
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NDP-MSH. As shown in Fig. 1, for MC3R, the preferential
order, NDP-MSH . a-MSH-ND . [Ahx4]a-MSH, is shown
with the IC50 values (nm) being 0.367 ^ 0.074, 47.20 ^ 9.08
and 106.70 ^ 32.25, respectively. For MC4R, the same
preferential order, NDP-MSH (0.566 ^ 0.194) . a-MSH-ND
(6.70 ^ 1.07) . [Ahx4]a-MSH (238.30 ^ 30.47), was obtained.
Although without the N-terminal three amino acid residues as
maintained in [Ahx4]a-MSH, a-MSH-ND still revealed a
higher binding affinity for both receptors than [Ahx4]a-MSH.
Based on the data obtained for a-MSH-ND, we truncated the
N-terminal Ahx4 and Asp5 residues of a-MSH-ND and
substituted its His6 residue by Gln or Asn. Then we tested
the binding affinity of these short peptides of truncated forms.
As a result, the truncated peptides revealed lower affinities for
the receptors than those untruncated substitutes (as seen in
Table 2). Regarding [Gln6]a-MSH-ND(6±10) and [Asn6]a-
MSH-ND(6±10), even though at the highest concentration
(1025 m), the displaced [125I]NDP-MSH were only 33.91% and
21.37%, respectively. The IC50 values (nm) for the MC3R were
shown as: a-MSH-ND(6±10), 4730.00 ^ 1180.93, [Gln6]a-
MSH-ND(6±10), 7156.00 ^ 5063.46, and [Asn6]a-MSH-
ND(6±10), 6712.00 ^ 4169.22, and for the MC4R,
827.00 ^ 208.73, 1297.00 ^ 392.28 and 1304.00 ^ 378.47,
respectively. To define further the role of the amino acid in
position 6 of a-MSH-ND in receptor-binding activity, we also
substituted His6 with Gln, Asn, Arg, and Lys, respectively, and
tested the binding affinities for the melanocortin receptors. As
shown in Fig. 2 (IC50 values shown in Table 2), all of the
substitutions at position 6 resulted in decreased binding
affinities for both receptors. In addition, the MC3R-binding
activity exhibited a different preference in the order a-MSH-
ND . [Arg6]a-MSH-ND . [Gln6]a-MSH-ND . [Asn6]a-
MSH-ND . [Lys6]a-MSH-ND with their IC50 values (nm)
being 47.20 ^ 9.08, 361.50 ^ 57.73, 1074.00 ^ 120.01,
1998.00 ^ 363.34 and 3340.00 ^ 877.05, respectively. In
addition, for MC4R, the preferential order was the same as
for MC3R: IC50 values (nm) were 6.70 ^ 1.07, 57.40 ^
8.37, 112.00 ^ 25.94, 171.20 ^ 14.81 and 214.50 ^ 40.63,
respectively.
After calculating the ratio of IC50MC3R/IC50MC4R, it was
found that [Lys6] a-MSH-ND exhibited the most selective
activity for MC4R. The ratio order of these peptides was
[Lys6]a-MSH-ND . [Asn6]a-MSH-ND . [Gln6]a-MSH-ND .
a-MSH-ND . [Arg6]a-MSH-ND . a-MSH-ND(6±10), [Gln6]
a-MSH-ND(6±10), [Asn6]a-MSH-ND(6±10) . NDP-MSH and
[Ahx4]a-MSH, and the corresponding ratio values were 14.03,
11.67, 9.59, 7.04, 6.29, 5.72, 5.52, 5.15, 0.65 and 0.45,
respectively.
Fig. 3. Measurement of intracellular cAMP in response to increasing
concentration of a-MSH analogues in CHO cell lines stably transfected
with MC3R and MC4R. Each experiment was performed in triplicate and
repeated twice.
Fig. 4. Measurement of intracellular cAMP in response to increasing
concentration of the a-MSH analogues in CHO cell lines stably
transfected with MC3R and MC4R. Each experiment was performed in
triplicate and repeated twice.
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Effects of the synthesized peptides on cyclic AMP
accumulation in CHO cells stably expressing MC3R or MC4R
Fig. 3 shows the receptor-mediated cAMP response of the
peptides at the MC3R and MC4R, except those in truncated
form: NDP-MSH also showed the highest potency of cAMP
generation for both the MC3R- and MC4R-expressing CHO
cells. [Arg6]a-MSH-ND exhibited higher potency than a-MSH-
ND at the MC3R, which was different from the binding assay
data shown above, but still lower than a-MSH-ND at the
MC4R, which was identical to the receptor-binding results. In
this study, [Asn6]a-MSH-ND displayed the weakest potency of
cAMP generation at the MC3R of all these peptides, while
being incapable of generating the maximum cAMP response at
the MC4R, like the other peptides. The potency order of all
the peptides tested was, at the MC3R, NDP-MSH . [Arg6]
a-MSH-ND . a-MSH-ND . [Ahx4]a-MSH, [Gln6]a-MSH-
ND . [Lys6]a-MSH-ND . [Asn6]a-MSH-ND; and at the
MC4R, NDP-MSH . a-MSH-ND . [Arg6]a-MSH-ND .
[Gln6]a-MSH-ND . [Lys6]a-MSH-ND . [Ahx4]a-MSH, .
[Asn6]a-MSH-ND. The saturable stimulation of cAMP
generation of [Asn6]a-MSH-ND in the MC4R, however, only
showed about one-third of the stimulation of the other ligands.
With regard to the truncated forms of peptides, as shown
in Fig. 4, they also displayed interesting results. Among
them, a-MSH-ND(6±10) gave a comparatively good cAMP
response, especially at the MC3R, exhibiting a high cAMP-
generating activity almost the same as that of a-MSH-ND when
concentratrion was high enough (1025 m). However, substitutions
of His6 with Gln or Asn resulted in a highly significant
decrease in their ability to stimulate cAMP formation, and
could not give rise to good activity even at a high concentration
(1025 m). In particular, the His6/Asn6 exchange led to a loss of
all biological activity at the MC3R, and caused an almost
complete loss of activity at the MC4R. As seen in Fig. 4,
[Gln6]a-MSH-ND(6±10) and [Asn6]a-MSH-ND(6±10) only
showed about on-sixth and one-third of maximum stimulation
Table 3. EC50 values (mean ^ SEM) of MSH analogues obtained from
computer analysis of dose±response curves on MC3R and MC4R
transfected CHO cells, together with the relative bioactivity ratios of the
melanocortin receptor subtypes. ±, The mature cAMP generation failed to
reach the maximum stimulation as shown by other ligands.
EC50 (nm)
Ratio of
Ligand MC3R MC4R MC3R/MC4R
NDP-MSH 0.174 ^ 0.052 0.126 ^ 0.020 1.381
[Ahx4]a-MSH 9.362 ^ 1.932 46.040 ^ 4.799 0.203
a-MSH-ND 1.523 ^ 0.707 0.780 ^ 0.405 1.953
[Gln6]a-MSH-ND 9.383 ^ 4.620 7.880 ^ 1.818 1.191
[Asn6]a-MSH-ND 271.800  21.948 ± ±
[Arg6]a-MSH-ND 0.381 ^ 0.157 4.858 ^ 0.949 0.078
[Lys6]a-MSH-ND 29.560 ^ 11.525 19.890 ^ 4.024 1.486
a-MSH-ND(6±10) 5.935  5.260 40.050 ^ 15.272 0.148
Fig. 5. Summary of NMR data for
[Gln6]a-MSH-ND (A), [Gln6]a-MSH-ND
(6±10) (B) and [Lys6]a-MSH-ND (C) showing
the sequential and short-range NOE
connectivity. Amide proton exchange rate
(B, amide protons that survived for < 20 h; A,
amide protons that were not detected after
10 min) and backbone NH-CaH vicinal coupling
constants (X, 3JHNa , 6Hz; shaded circle,
6.5Hz , 3JHNa # 8Hz; W,
3JHNa . 8Hz).
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of a-MSH-ND and a-MSH-ND(6±10). The corresponding
EC50 values of these a-MSH analogues are given in Table 3.
NMR resonance assignments and secondary structures of
a-MSH analogues
Complete proton resonance assignment followed standard
sequential analysis [29] based on two-dimensional TOCSY
and NOESY spectra collected in H2O solution. Chemical
shifts and temperature coefficients of [Gln6]a-MSH-ND,
[Gln6]a-MSH-ND(6±10) and [Lys6]a-MSH-ND peptides are
summarized in Table 4. The data of hydrogen exchange of three
a-MSH analogues are displayed in Fig. 5. The NH protons
Arg8 in both [Gln6]a-MSH-ND and [Gln6]a-MSH-ND(6±10)
exhibited slower hydrogen exchange rates, suggesting a
manifestation of a better-protected amide proton, in other
words, a folded structure for this region. However, all backbone
amide protons of [Lys6]a-MSH-ND were exchanged quickly.
The sequential and short-range NOE connectivities for
three a-MSH analogues are summarized in Fig. 5. In [Gln6]
a-MSH-ND, a daN(i,i + 3) NOE indicative of b-turn con-
formation was observed between Asp5 and Arg8. This finding
was also supported by daN(i,i + 2) and dNN(i,i + 2) NOEs
together with a small vicinal 3JHNa coupling constant of d-Phe7
(, 6Hz). The chemical shift differences [30] of Ca protons of
[Gln6]a-MSH-ND were computed using the random coil
values and showed significant deviations for residues of Asp5
[0.51 p.p.m. (^ 0.10)] and Arg8 [0.54 p.p.m. (^ 0.10)],
respectively. This data supported the notion that [Gln6]
a-MSH-ND has a propensity to form a type I 0 b-turn,
which is a mirror image corresponding to a type I b-turn,
around Asp5±Gln6±dPhe7±Arg8.
Figure 5B shows the sequential and short-range NOE
connectivity of [Gln6]a-MSH-ND(6±10). A number of
short-range NOEs were detected around the message
sequence of the peptide. The stretch of medium daN(i,i + 1)
NOEs for Gln6±Arg8 were observed; however, neither the
daN(i,i + 2) nor daN(i,i + 3), NOEs indicative of stable tight
b-turns, were detected. On the basis of a dNN(i,i + 2)
between Gln5 and Arg8 together with a small 3JHNa coupling
constant of d-Phe7 residue, [Gln6]a-MSH-ND(6±10)
adopted a g-turn conformation composed of three residues
Gln6-d-Phe7-Arg8. This data is also supported by the
temperature coefficients and hydrogen exchange data of
[Gln6]a-MSH-ND(6±10) (Table 4 and Fig. 5B). In addition,
Table 4. Proton NMR chemical shift assignments and temperature coefficients for [Gln6]a-MSH-ND, [Gln6]a-MSH-ND(6±10) and [Lys6]a-MSH-
ND in 90% H2O/10% D2O. Chemical shifts are expressed relative to internal sodium 4,4-dimethyl-4-silapentane 1-sulfonate. The samples were maintained
at 10 8C, pH 7.0. The temperature coefficient values were calculated using the equation D(dNH)/DT  1023.
Peptides Residues NH CaH CbH Others p.p.b./K
[Gln6]a-MSH-ND Ahx4 8.44 4.13 1.58 CgH2(1.58) CdH3(1.13) ±5.9
Asp5 8.58 4.53 2.71 +0.8
Gln6 8.22 4.27 2.09, 2.18 CgH2(1.89) N1H2(6.96, 7.58) ±7.3
d-Phe7 8.61 4.54 3.07, 3.16 2,6H(7.32) 4H(7.36) 3,5H (7.43) ±6.4
Arg8 8.37 4.12 1.41 CgH2(0.98) CdH2(2.99) N1H(7.20) ±1.4
Trp9 8.27 4.66 3.40, 3.37 2H(7.35) 4H(7.72) 5H(7.22)
6H(7.29) 7H(7.54) NH(10.28)
±6.8
Lys10 8.07 4.15 1.56 CgH2(1.34) CdH2(1.62)
C1H2(2.879) NH3
+(7.64)
±6.8
[Gln6]a-MSH-ND(6±10) Gln6 8.36 4.38 1.86, 1.94 CgH2(2.14) N1H2(7.55, 6.96) +0.2
d-Phe7 8.73 4.63 3.10, 3.04 2,6H(6.93) 3,5H(7.34) 4H(7.01) ±6.0
Arg8 8.40 4.14 1.57, 1.40 CgH2(1.12, 1.00) CdH2(3.00)
N1H(7.11)
+0.6
Trp9 8.23 4.71 3.37 2H(7.32) 4H(7.69) 5H(7.18)
6H(7.26) 7H(7.51) NH(10.22)
±6.2
Lys10 8.00 4.14 1.75, 1.62 CgH2(1.28) C1H2(2.98) NH3
+(7.58) ±7.2
[Lys6]a-MSH-ND Ahx4 8.31 3.88 1.43 CgH2(1.43) CdH3(0.98, 1.09) ±6.1
Asp5 8.50 4.38 2.83, 2.77 ±7.4
Lys6 8.14 4.11 1.72, 1.65 CgH2(1.26, 1.18) CdH2(1.57, 1.65)
C1H2(2.88) NH3
+(7.56)
±5.9
d-Phe7 8.52 4.40 3.05, 3.08 2,6H(7.25) 3,5H(7.36) 4H(7.30) ±6.2
Arg8 8.40 3.94 1.19 CgH2(0.77) CdH2(2.97) N1H(7.10) ±5.0
Trp9 8.18 4.44 3.31 2H(7.08) 4H(7.51) 5H(7.13)
6H(7.21) 7H(7.31) NH(10.09)
±7.7
Lys10 8.06 3.94 1.48 CgH2(1.00) CdH2(1.35) C
1H2(2.92)
NH3
+(7.56)
±7.1
Table 5. Torsion angles f and c (degress) for central residues in turn
conformations of three a-MSH analogues.. Torsion angles of a-MSH
analogues were measured from the average REM structure. The central
residue involved in g-turn is i + 1; the two residues for b-turn are i + 1 and
i + 2, respectively.
Peptides Central residues
Torsion angles
fi + 1 ci + 1 fi + 2 ci + 2
[Gln6]a-MSH-ND Gln6/d-Phe7 64 33 86 ±10
[Gln6]a-MSH-ND(6±10) d-Phe7 ±75 58
[Lys6]a-MSH-ND Lys6/d-Phe7 ±106 ±170 ±36 ±91
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the deviations from random coil chemical shifts for the CaH
resonances suggested the existence of a secondary structural
element for [Gln6]a-MSH-ND(6±10).
For [Lys6]a-MSH-ND, short-range NOEs for turn confor-
mation around the message sequence were not observed
(Fig. 5C). Most residues in this peptide showed the large
3JHNa as well as a rapid exchange of NH protons.
Solution structures of [Gln6]a-MSH-ND,
[Gln6]a-MSH-ND(6±10) and [Lys6]a-MSH-ND
Using the experimental constraints from NMR data, 30
structures of all a-MSH analogues were calculated by distance
geometry followed by a simulated-annealing method. The
quality of the final structures was estimated on the grounds of
the number of constraint violations, minimal energy and error
factors based on geometry and constraints. Among the
simulated annealing structures (,SA.k), 16 of [Gln6]a-
MSH-ND, 27 of [Gln6]a-MSH-ND(6±10) and 21 of [Lys6]
a-MSH-ND demonstrated no constraint violations greater than
0.03 nm for distances and 3 8 for torsion angles. Each average
structure was calculated from the geometrical average of final
structures and followed the restraints energy minimization
(REM) procedure. The backbone conformations are super-
imposed from Asp5 to Arg8 (Fig. 6A) and the average REM
structure (,SA.kr) of [Gln6] a-MSH-ND showed a 0.042 nm
rmsd value for backbone heavy atoms with respect to
16 ,SA. k structures. All of the structures displayed small
deviations from idealized covalent geometry. An inspection of
the ,SA. kr structure clearly showed that [Gln6]a-MSH-ND
preferred type I 0 b-turn conformation residues of Asp5±Gln6±
dPhe7±Arg8. The backbone structures of [Gln6]a-MSH-ND
showed a standard hydrogen bond between carbonyl oxygen of
Asp5 and amide hydrogen of Arg8. This was supported by the
temperature coefficients and slowly exchanged amide hydrogen
data. Table 5 shows the f and c torsion angles of the central
residues for ,SA. kr structure. The dihedral angles measured
from the ,SA. kr structure also supported the tight turn,
which includes the residues Asp5-Gln6-d-Phe7-Arg8.
A best-fit superposition of all 27 ,SA. k and ,SA. kr of
[Gln6]a-MSH-ND(6±10) is shown in Fig. 6B. The average
REM structure of [Gln6]a-MSH-ND(6±10) was very well
converged for all backbone heavy atoms with respect to
27 ,SA. k structures (rmsd value of 0.036 nm). All ,SA. k
and ,SA. kr structures showed a hydrogen bond between
carbonyl oxygen of Gln6 and amide hydrogen of Arg8. Table 5
lists the backbone torsion angles for central residues for a-MSH
analogues. This data demonstrated that the three residues
Gln6±dPhe7±Arg8 of [Gln6]a-MSH-ND(6±10) adopted a
reverse g-turn conformation.
Fig. 6. Final simulated-annealing structures
of [Gln6]a-MSH-ND (A), [Gln6]a-MSH-ND
(6±10) (B) and [Lys6]a-MSH-ND (C).
Superposition of the final ,SA. k structures
(thin line) (16, 27 and 21 structures for
[Gln6]a-MSH-ND, [Gln6]a-MSH-ND(6±10)
and [Lys6]a-MSH-ND, respectively) over the
average REM structure (thick line) displayed in
stereoview. All backbone atoms of three a-MSH
analogues are superimposed from Asp4 to Arg8
except for [Gln6]a-MSH-ND(6±10) (from Gln6
to Arg8).
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Fig. 6C shows the superposition of the final 21 ,SA. k
structures of [Lys6]a-MSH-ND over ,SA. kr. The rmsd of
,SA. k structures for backbone atoms was 0.058 nm to
,SA. kr structures. The backbone torsion angles for all
21 ,SA. k structures indicated that all f and c values were
distributed in energetically acceptable regions. For [Lys6]
a-MSH-ND, a turn conformation appeared comprising the
residues Asp5-Lys6-d-Phe7-Arg8. The peptide formed a right
angle twist to make a bend conformation. This conformation
distorted the orientation of Asp5 and resulted in the weak
hydrogen bond between the carbonyl oxygen of Asp5 and
amide hydrogen of Arg8. NOEs around the message sequence
for the standard b-turn were not observed and all residues
showed the large 3JHNa together with a fast hydrogen exchange
rate for all backbone amide protons.
D I S C U S S I O N
During states of positive energy balance, the adipose mass
expands, leptin concentrations increases, and the resulting
output from the brain favours reduced food intake and a
reduction in the size of the adipose mass [31]. The
melanocortin neurone appears to be a target of leptin action
because leptin receptors are expressed on POMC neurones in
the arcuate nucleus [32]. Recent reports with knockout
techniques [33,34] and intracerebroventricular injection of the
cyclic MSH analogues SHU9119 and MTII [12] linked the
MC4R to feeding behaviour and weight homeostasis. MC3Rs
are also abundantly expressed in the brain and peripheral tissues
such as placenta, gut tissues and the human heart [14]. The
physiologic roles of the MC3R, however, are not yet fully
understood. Until now, most of the known melanocortin
analogues have shown only minimal discrimination between
the MC3R and the MC4R [17]. As MC4R-selective substances
have been considered as potential candidates for the treatment
of eating disorders, including obesity and anorexia, any
analogue which shows significant discrimination will be
worthwhile for studying the physiologic roles of melanocortin
receptor subtypes and for studying the structures and functions
of a-MSH analogues.
All of the natural melanocortins contain the conserved core
structure (i.e. His6-Phe7-Arg8-Trp9), and each of the core
residues has been thought to exhibit an important effect for
biological activity [35±38]. A cyclic form of MTII (Ac-
Ahx-cyclic[Asp-His-(d-Phe)-Arg-Trp-Lys]-NH2) has been
designed as a lead compound for structure±function studies
on human melanocortin receptors [39]. In our previous
NMR study, a-MSH formed a hairpin loop conformation,
whereas a-MSH-ND, a linear form of MTII, preferred a type I
b-turn comprising the residues Asp-His6-(d-Phe7)-Arg8 [19].
To further investigate the role of type I b-turn and to make
shorter analogues, we truncated the N-terminal Ahx4 and Asp5
residues of a-MSH-ND and substituted the His6 residue with
Gln or Asn residue, and then observed the structural traits of
[Gln6]a-MSH-ND(6±10) by NMR. Truncation of Ahx4 and
Asp5 of a-MSH-ND decreased remarkably the receptor-
binding and cAMP-generating activity. [Gln6]a-MSH-ND
(6±10) was almost unable to activate both receptors, even
though it could bind to both receptors. In NMR study, although
[Gln6]a-MSH-ND(6±10) is composed of only five amino acid
residues, it still revealed a very stable structure and a tight
g-turn composed of Gln6-d-Phe7-Arg8. Therefore, a plausible
explanation for the remarkable loss of the receptor-binding and
cAMP-generating activity of the truncated analogues might be
that these short analogues could no longer maintain a stable
classic type I b-turn conformation. On the other hand,
[His6]a-MSH-ND(6±10) was able to generate the maximum
stimulation of the receptors at a higher concentration (1025 m),
whereas [Gln6]a-MSH-ND(6±10) was almost completely
incapable of stimulating both receptors. This suggested that
the degree of flexibility and ability of truncated analogues for
receptor activation might be partially dependent on the flexible
free N-terminal end of the sixth residue itself.
a-MSH-ND prefers a type I b-turn and the position of the
imidazole ring of the His6 residue was displaced by the
substitution of Phe7 by d-Phe7 in our previous NMR study
[19]. Therefore, we changed the His6 residue of a-MSH-ND to
Gln, Asn, Arg or Lys to analyse the contribution of the His6
residue on receptor binding and activation. The replacement
of His6 by Asn6 and Gln6 decreased the receptor-binding
activity by 22.8- and 42.3-fold for the MC3R, and by
25.6- and 16.7-fold for the MC4R, respectively. The structure
of [Gln6]a-MSH-ND exhibited a stable type I 0 b-turn
comprising residues Asp5, Gln6, d-Phe7 and Arg8. Compared
with a-MSH-ND, the substitution of His6 by Arg6 and Lys6,
two positively charged residues, decreased the receptor-binding
activity by 7.7- and 70.8-fold for the MC3R, and by 8.6- and
35.5-fold for the MC4R, respectively. [Arg6]a-MSH-ND
showed a significantly higher binding affinity to both receptors
than [Lys6]a-MSH-ND. This suggested that, for these two
analogues, the different potencies were probably the result of
the distinct sizes of their sixth residues rather than the electrical
charge. Of the substituted peptides, [Lys6]a-MSH-ND showed
the lowest binding affinity and a greatly decreased cAMP-
generating activity. Even for the MC4R, the binding affinity of
[Lys6]a-MSH-ND decreased < 36-fold compared with that
of a-MSH-ND. In NMR, [Lys6]a-MSH-ND demonstrated a
g-turn like conformation around Lys6-dPhe7-Arg8. These
dramatic changes of binding affinity shown above could be
explained easily from our structural studies. Taken together, our
results suggested that the type I b-turn could affect both potencies
and prolonged biological activity of melanotropin peptides.
In this study, the preference order of receptor affinities of
NDP-MSH, a-MSH-ND and [Ahx4]a-MSH for both the MC3R
and the MC4R was NDP-MSH . MTII < a-MSH-ND .
[Ahx4]a-MSH, in which the MTII data was obtained from
SchioÈth [36]. The higher receptor-binding activity compared to
the truncated analogues suggested that the N or C terminus of
NDP-MSH may play a certain role in both the binding affinity
and selectivity for MC4R. Recently, SchioÈth et al. also reported
that the C terminus was more important than the N
terminus for binding to the MC4R after comparing NDP-
MSH(1±9) and NDP-MSH(4±13) [40]. NDP-MSH, even MTII
and a-MSH-ND, of which Phe7 is substituted by d-Phe7,
showed a remarkably higher MC4R-selective affinity and
potency in receptor activation compared with [Ahx4]a-MSH,
whereas all of the His6-substituted a-MSH-ND analogues still
preserved MC4R preference in receptor-binding activity. In
contrast, Ahx4-and Asp5-truncated a-MSH-ND(6±10) showed
the loss of MC4R preference in cAMP-generating activity. Loss
of MC4R preference in cAMP-generating activity was also
observed in [Arg6]a-MSH-ND. Although the different bio-
logical activity of these analogues for the MC3R and the MC4R
may arise not only due to the subtype differences, but also due
to species difference, these findings, taken together, support the
previous observation that the substitution of Phe7 by d-Phe7
could be decisive in maintaining high receptor activation and in
obtaining MC4R selectivity by enhancing hydrophobic inter-
action [16,17,41,42]. It may also suggest that the sixth residue of
a-MSH analogues is important for selective receptor activation.
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In conclusion, we have shown that a type I b-turn backbone
structure comprising the residues Asp5-His6-(d-Phe7)-Arg8
is important for receptor binding and activation, as well as
the selectivity of a-MSH analogues. Therefore, a potent
MC4R-selective substance could be developed by extensive
modifications of core residues, while preserving the type I
b-turn structure.
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